(Q33538430)

27 July 2017

1 reference

title

Prognostic and predictive value of p53 and p21 in breast cancer (English)

1 reference

27 July 2017

1 reference

Elledge RM

1

1 reference

27 July 2017

Allred DC

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Breast Cancer Research and Treatment

27 July 2017

1 reference

27 July 2017

52

1 reference

27 July 2017

79-98

1 reference

27 July 2017

1-3

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006163101948

27 July 2017

0 references

cites work

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

The p53-mdm-2 autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Inhibition of DNA replication factor RPA by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Prognostic significance of TP53 alterations in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 protein and vimentin in invasive ductal NOS breast carcinoma--relationship with survival and sites of metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 expression and the result of adjuvant therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 mutations and overexpression in locally advanced breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Wild-type p53 activates transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Prognostic significance of p53 gene alterations in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Immunohistochemical Detection of p53 and c-erbB-2 Proteins: Prognostic Significance in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Overexpression of p53 and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Expression of p53 protein has no independent prognostic value in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Abnormal expression of MDM-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Overcoming complexities in genetic screening for cancer susceptibility

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Molecular fish on chips

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

WAF1/CIP1 protein expression in human breast tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006163101948

7 January 2021

Identifiers

DOI

10.1023/A:1006163101948

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference